Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Use a straightforward framework to decide between 3-6 or 12 months of expenses. Includes factors like income stability and debt levels.
18,776 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
This in-depth guide breaks down Employers EIG 2025 earnings, focusing on Q4 results, guidance, and what it means for ...
The Mexican army killed cartel chief El Mencho in a late Sunday operation, prompting airlines to suspend flights to P...
In a choppy market, a dependable income stock is turning heads in 2026. This article breaks down why this resilient d...
Retail investors are increasingly offered access to private-market products as Wall Street courts Main Street. But ex...
The AI rush has put NVIDIA and TSMC in the spotlight. This guide breaks down the opportunity, risks, and what it take...
The plant-based meat craze brought BYND into the spotlight, but the path forward is uncertain. This guide examines wh...
Bitcoin surges past $71,000 as South Korea's stock market suffers a sweeping rout, signaling a potential decoupling i...
President Trump ousted Homeland Security Secretary Kristi Noem on Thursday, signaling a rapid leadership shift and na...
This week brought a sharp pullback in precious metals equities. We break down what drove the move, how it affects New...
A high-profile insider sale can shake investor nerves. This guide explains what the Dropbox stock sell after event mi...
Artificial intelligence and cryptocurrency have transformed conversations about money. This guide explains what to lo...